Evidence-Based Guidelines Issued by ASTRO Support Sensus Healthcare’s SRT Technology as the First-Line Alternative to Surgery for Treating Non-Melanoma Skin Cancer
Influential professional organization recommends radiotherapy as the primary non-surgical alternative for patients with basal cell or cutaneous squamous cell carcinomas BOCA RATON, Fla, July 14, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, and the leading provider of superficial radiotherapy […]
Sensus Healthcare to Present at COVID-19 Webinar Hosted by Maxim Group on July 16th
BOCA RATON, Fla., July 13, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announced today that Joe Sardano, Sensus’ chief executive officer has been invited to present at the Re-Engaging Medical Practices in an Era of COVID-19 webinar, presented by […]
Sensus Healthcare’s CEO to Participate in Dermatology Practice Panel Discussion as Part of the Fall Clinical Virtual Grand Rounds Weekly Series
BOCA RATON, Fla. , June 30, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that Joe Sardano, the company’s chief executive officer, will participate in a panel discussion today at the Fall Clinical Virtual Grand Rounds Weekly Continuing Education […]
Sensus Healthcare Announces CME Presentation by Dr. Jeffrey S. Fromowitz Today at the Fall Clinical Virtual Grand Rounds Series
BOCA RATON, Fla, June 24, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that Jeffrey S. Fromowitz, M.D. will discuss the use of superficial radiation therapy at the Fall Clinical Virtual Grand Rounds Weekly Continuing Education Series today. The […]
Sensus Healthcare and David Goldberg, M.D., J.D. to Host a Virtual Program on Dermatology Medical and Legal Issues in the Era of COVID-19
June 18 Event is the Third in a Series of Topical Discussions BOCA RATON, Fla., June 03, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that it will host a program titled “Medical-Legal Issues in the Era of COVID-19” […]
Sensus Healthcare Reports First Quarter 2020 Financial Results
Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., May 07, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three months ended March 31, 2020. Highlights from the first quarter […]
Sensus Healthcare to Host First Quarter 2020 Financial Results and Business Update Conference Call on May 7, 2020
BOCA RATON, Fla. , April 30, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 7, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the first […]
Sensus Healthcare Announces Publication of Research on Long-term Efficacy and Safety of Superficial Radio Therapy in Journal of Drugs in Dermatology
Retrospective registry study showed a 98.9% non-recurrence rate after 85 months in subjects with non-melanoma skin cancer treated with SRT BOCA RATON, Fla. , March 03, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, today announced that results […]
Sensus Healthcare Reports Fourth Quarter and Full Year 2019 Financial Results
Fourth quarter net income up 10-fold to $1.0 million, diluted EPS of $0.06 Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Feb. 13, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results […]
Sensus Healthcare to Host Fourth Quarter 2019 Financial Results and Business Update Conference Call on February 13, 2020
BOCA RATON, Fla. , Feb. 06, 2020 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 13, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the fourth […]
